PDEX

Pro-Dex Inc
NASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$229.90M
P/E Ratio
17.38
EPS
$4.13
Beta
0.06
52W High
$77.00
52W Low
$23.47
50-Day MA
$64.06
200-Day MA
$53.70
Dividend Yield
—
Profit Margin
17.60%
Forward P/E
23.42
PEG Ratio
0.00

About Pro-Dex Inc

Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company is headquartered in Irvine, California.

Official WebsiteUSAFY End: June

Fundamentals

Revenue (TTM)$77.55M
Gross Profit (TTM)$24.34M
EBITDA$14.38M
Operating Margin17.30%
Return on Equity32.40%
Return on Assets12.00%
Revenue/Share (TTM)$24.04
Book Value$14.95
Price-to-Book4.87
Price-to-Sales (TTM)2.96
EV/Revenue3.115
EV/EBITDA11.95
Quarterly Earnings Growth (YoY)143.40%
Quarterly Revenue Growth (YoY)16.60%
Shares Outstanding$3.20M
Float$1.76M
% Insiders36.29%
% Institutions31.74%

Historical Volatility

HV 10-Day
53.61%
HV 20-Day
92.24%
HV 30-Day
76.06%
HV 60-Day
66.17%
HV Rank
81.3%

Volatility is currently contracting

Latest News

Pro-Dex: Still A Buy, But Don't Chase

Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contract now runs through December 2028, reducing potential near-term risks in that sense. Also, their APM acquisition gives them more control over their supply chain and brings some potential aerospace/defense optionality.

Seeking Alpha5/15/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PDEX and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/26/2026